Medcorp Limited (TTSE:MED)
Trinidad and Tobago
· Delayed Price · Currency is TTD 45.00
0.00 (0.00%)
At close: Mar 6, 2026
Medcorp Cash Flow Statement
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 45.35 | 41.31 | 57.07 | 24.13 | 24.49 | 17.65 |
| Depreciation & Amortization | 17.85 | 16.58 | 10.99 | 8.16 | 4.94 | 5 |
| Loss (Gain) From Sale of Assets | - | - | 0 | -0.12 | - | - |
| Asset Writedown & Restructuring Costs | - | - | -0 | - | - | - |
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -1.43 |
| Loss (Gain) on Equity Investments | -4.87 | -4.83 | -4.98 | -1.72 | -1.99 | -3.65 |
| Provision & Write-off of Bad Debts | -1.4 | -1.4 | 0.77 | 1.06 | 0.87 | -0.28 |
| Other Operating Activities | -23.1 | -26.18 | 9.96 | 0.27 | 3.69 | 5.25 |
| Change in Accounts Receivable | 9.07 | 4.31 | -17.14 | 8.39 | -7.89 | 9.36 |
| Change in Inventory | -2.24 | -0.83 | 0.44 | -0.12 | -0.96 | -1.48 |
| Change in Accounts Payable | 2.45 | 2.68 | 0.96 | 7.7 | -1.82 | -2.49 |
| Change in Other Net Operating Assets | 0.6 | -6.92 | -23.77 | -3.83 | -0.29 | -3.87 |
| Operating Cash Flow | 43.72 | 24.73 | 34.31 | 43.91 | 21.04 | 24.06 |
| Operating Cash Flow Growth | 27.43% | -27.92% | -21.87% | 108.66% | -12.55% | - |
| Capital Expenditures | -5.26 | -4.6 | -5.6 | -18.5 | -15.38 | -4.29 |
| Sale of Property, Plant & Equipment | 0.03 | 0.03 | - | 0.52 | - | - |
| Investment in Securities | -15 | - | - | 0.68 | 7.91 | - |
| Other Investing Activities | 2 | - | 4.5 | 4.65 | 2.3 | 11.25 |
| Investing Cash Flow | -18.22 | -4.57 | -1.1 | -12.64 | -5.17 | 6.96 |
| Long-Term Debt Issued | - | - | - | 4.53 | 5.69 | - |
| Long-Term Debt Repaid | - | -19.89 | -16.64 | -7.49 | -7.49 | -7.38 |
| Net Debt Issued (Repaid) | -20.86 | -19.89 | -16.64 | -2.96 | -1.8 | -7.38 |
| Common Dividends Paid | -37.75 | -18.7 | -7.48 | -28.89 | -11.22 | -20.21 |
| Other Financing Activities | -0.87 | -1 | -0.61 | -0.9 | -0.44 | -0.32 |
| Financing Cash Flow | -42.68 | -39.59 | -24.73 | -32.75 | -13.46 | -27.91 |
| Net Cash Flow | -17.19 | -19.44 | 8.48 | -1.49 | 2.41 | 3.11 |
| Free Cash Flow | 38.46 | 20.12 | 28.71 | 25.41 | 5.66 | 19.77 |
| Free Cash Flow Growth | 33.98% | -29.89% | 12.96% | 349.02% | -71.38% | - |
| Free Cash Flow Margin | 31.74% | 16.46% | 22.60% | 20.79% | 4.96% | 19.13% |
| Free Cash Flow Per Share | 4.91 | 2.69 | 3.84 | 3.40 | 0.76 | - |
| Cash Interest Paid | 0.87 | 1 | 0.61 | 0.9 | 0.44 | 0.32 |
| Cash Income Tax Paid | 5.64 | 13.06 | 8.06 | 8.95 | 8.78 | 3.59 |
| Levered Free Cash Flow | - | 22.89 | -7.16 | 16.42 | 0.1 | - |
| Unlevered Free Cash Flow | - | 26.61 | -5.16 | 17.95 | 1.54 | - |
| Change in Working Capital | 9.88 | -0.75 | -39.5 | 12.14 | -10.95 | 1.52 |
Source: S&P Capital IQ. Standard template. Financial Sources.